As on 30th June 2014, the company had approvals of 13 ANDAs in US, 14 molecules in the Europe and 11 molecules in Other Regulated Markets (ORM), additionally, there are 28 ANDAs in the US, 8 molecules in Europe and 10 molecules in ORM, which are ... Web Newswire, 1 week ago
Claris Lifesciences : gets MHRA nod for new plant - 4 Traders, 3 weeks ago
Claris Lifesciences plans to expand capacity at new plant - Business Standard, 4 weeks ago
2 images for "claris lifesciences"
Claris Lifesciences Ltd has reported net profit of Rs15 crore for Apr- Jun 2014 ( Rs18 crore for Apr- Jun 2013 ). Its revenues have declined to Rs151 crore ( Rs202 crore ). The company had transferred its infusion business in India and emerging ...4 Traders, 1 month ago Claris Lifesciences net declines by 14.7% in Q2 PharmaBiz, 1 month ago Claris Life consolidated Jun '14 sales at Rs 156.35 crore Money Control, 1 month ago Claris Life consolidated net profit at Rs 15.4 cr in June 14 Business Standard India, 1 month ago
Claris Lifesciences at its meeting held on August 11, 2014, has approved and taken on record the appointment of Ms. Milina Bose as an Additional Non Executive Non Independent Woman Director w.e.f. August 11, 2014 on Board of the Company.Money Control, 1 month ago Claris Lifesciences: Updates on outcome of AGM Money Control, 2 months ago Outcome of board meeting of Claris Lifesciences Business Standard, 2 months ago Claris Lifesciences: Outcome of board meeting Money Control, 2 months ago
Stock of Claris Life ended the day 3.56 per cent higher at Rs 181.60 on the BSE. In intra-day, it gained 6.33 per cent to Rs 186.45. ");document.close();})();' frameborder="0" scrolling="no" width="640" height="160"> On the volume front, 2.25 lakh shares of ...Economic Times, 4 weeks ago Claris Lifesciences shares up 3.5 per cent on BSE Economic Times, 4 weeks ago Claris Lifesciences shares up over 3% on BSE Business Standard, 2 months ago
Claris Lifesciences rose 2.15% to Rs 185.50 at 9:19 IST on BSE, with the stock extending Thursday's 3.56% gains triggered by the company receiving MHRA nod for its newly commissioned plant. Meanwhile, the S&P BSE Sensex was up 109.08 points or ...Capital Market, 4 weeks ago
Claris Lifesciences EBITDA for H1CY14 stood at Rs. 570 million. Claris Lifesciences Ltd. announced its quarterly and half yearly un-audited financial results for the quarter and half year ended 30th June 2014 at its board meeting held at its registered office ...India Infoline, 1 month ago Claris Lifesciences posts Rs 1,511 million revenue at Q2CY14 Express Pharma, 1 month ago CLARIS LIFESCIENCES LIMITED UN-AUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30th JUNE 2014 Web Newswire, 1 month ago
US drug regulator termed Claris' facility as acceptable after the inspectionBusiness Standard, 2 months ago USFDA finds Claris Lifesciences plant acceptable Business Standard, 2 months ago Claris Lifesciences advances as USFDA finds plant acceptable India Infoline, 2 months ago US FDA finds Claris Lifesciences plant acceptable; stock up 4% Business Standard, 2 months ago
It's earnings season. www.indiainfoline.com, a part of the IIFL Group, presents you real-time, comprehensive, and in-depth analysis of company earnings to give you that investment edge. The 'Results Calendar' helps you keep track of all important results. The ...India Infoline, 2 months ago Pre-Budget Expectation: Claris Lifesciences India Infoline, 2 months ago
Claris Lifesciences jumped 5.03% to Rs 167 at 15:19 IST on BSE after the company said its board approved transferring the speciality injectable business by way of a slump sale to a wholly-owned subsidiary of the company.Business Standard, 2 months ago
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved Claris Lifesciences newly commissioned facility (Plant 2). The latest approval will pave for Cbris Lifesciences to improve capacities to develop in the regulated ...Pharmaceutical Business Review, 4 weeks ago
on your WebpageAdd Widget >Get your members hooked!